business
China surpassing Europe in Drug Innovation and Development, Pfizer Inc. (PFE) Executive says
Key takeaways
- China surpassing Europe in Drug Innovation and Development, Pfizer Inc.
- (NYSE:PFE) 's Chief International Commercial Officer, Alexandre de Germay, said China has moved ahead of Europe in pharmaceutical innovation and drug development.
- De Germay commented that China now has "40% of all clinical studies in oncology" globally.
China surpassing Europe in Drug Innovation and Development, Pfizer Inc. (PFE) Executive says Fatima Gulzar Mon, June 29, 2026 at 2:58 AM GMT+7 1 min read PFE Pfizer Inc. (NYSE:PFE) is among the Best Healthcare Stocks.
On June 23, Reuters reported that Pfizer Inc. (NYSE:PFE) 's Chief International Commercial Officer, Alexandre de Germay, said China has moved ahead of Europe in pharmaceutical innovation and drug development.
De Germay commented that China now has "40% of all clinical studies in oncology" globally. He pointed out that the biopharma firm believes clinical development can move three times faster in China and at roughly half the cost compared with Europe.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop